• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Market Research Reports > Pharmaceutical > Generic Drugs
Search for Annual Information Service
Browse by Region

Generic Drugs Market Research Reports

Our range of reports on generics, biosimilars and biobetters will help you to gain an accurate view of the current and future generics landscape. They will help you gain insight as to how to discover techniques to counter patent expiry, manage drug life cycles, identify opportunities for market entry, and benchmark performance.

Filter
Title Search
1 - 25 of 141 Products Sort by Display
Global Biosimilar monoclonal antibodies (mAbs) Market 2020-2024
Global Biosimilar monoclonal antibodies (mAbs) Market 2020-2024
Published by
TechNavio (Infiniti Research Ltd.)
Product code
932417
Published
April 10, 2020
Content info
120 Pages
Price
USD 2500
Sample available
Oncology Biosimilars Market Global Report 2020-30
Oncology Biosimilars Market Global Report 2020-30
Published by
The Business Research Company
Product code
931982
Published
April 10, 2020
Content info
Price
USD 4000
Sample available
Biosimilars Market Global Report 2020-30
Biosimilars Market Global Report 2020-30
Published by
The Business Research Company
Product code
931981
Published
April 10, 2020
Content info
Price
USD 4000
Sample available
Oral Biologics & Biosimilars Market Global Report 2020-30
Oral Biologics & Biosimilars Market Global Report 2020-30
Published by
The Business Research Company
Product code
931980
Published
April 10, 2020
Content info
Price
USD 4000
Sample available
*
Global Biosimilar Monoclonal Antibody Market Size study, by Type (Synthetic Chemicals, Biopharmaceuticals and Others), By Application (Chronic & Autoimmune Diseases, Oncology and Others) and Regional Forecasts 2019-2026
Published by
Bizwit Research & Consulting LLP
Product code
931235
Published
April 1, 2020
Content info
Price
USD 4950
Sample available
Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house, Contract), Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease) - Global Forecast to 2025
Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house, Contract), Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease) - Global Forecast to 2025
Published by
MarketsandMarkets
Product code
930112
Published
March 24, 2020
Content info
187 Pages
Price
USD 4950
Sample available
*
Biosimilars Market - Forecast (2020 - 2025)
Published by
IndustryARC
Product code
409046
Published
March 11, 2020
Content info
112 Pages
Price
USD 4500
Sample available
Global Generic Pharmaceutical Partnering Terms and Agreements 2014-2020: Deal trends, players and financials
Global Generic Pharmaceutical Partnering Terms and Agreements 2014-2020: Deal trends, players and financials
Published by
Current Partnering, a division of Wildwood Ventures Limited
Product code
712889
Published
March 1, 2020
Content info
250+ Pages
Price
USD 3495
Sample available
Biosimilar Index: Tracking the Biosimilar Development Landscape
Biosimilar Index: Tracking the Biosimilar Development Landscape
Published by
FirstWord
Product code
298599
Published
annual subscription
Content info
Price
Contact Us
Sample available
Global Biosimilar Monoclonal Antibodies Forecast 2020-2030: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab
Global Biosimilar Monoclonal Antibodies Forecast 2020-2030: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab
Published by
Visiongain Ltd
Product code
933209
Published
February 28, 2020
Content info
198 Pages
Price
USD 4605
Sample available
Biosimilars in Immunology
Biosimilars in Immunology
Published by
GlobalData
Product code
929733
Published
February 28, 2020
Content info
137 Pages
Price
USD 7995
Sample available
*
Generics Global Group of Eight (G8) Industry Guide 2014-2023
Published by
MarketLine
Product code
353040
Published
February 27, 2020
Content info
181 Pages
Price
USD 1495
Sample available
Generics Global Industry Guide 2014-2023
Generics Global Industry Guide 2014-2023
Published by
MarketLine
Product code
251357
Published
February 27, 2020
Content info
271 Pages
Price
USD 1495
Sample available
Generics Top 5 Emerging Markets Industry Guide 2014-2023
Generics Top 5 Emerging Markets Industry Guide 2014-2023
Published by
MarketLine
Product code
353043
Published
February 26, 2020
Content info
138 Pages
Price
USD 995
Sample available
Generics Global Industry Almanac 2014-2023
Generics Global Industry Almanac 2014-2023
Published by
MarketLine
Product code
353039
Published
February 26, 2020
Content info
490 Pages
Price
USD 2995
Sample available
*
Generics BRIC (Brazil, Russia, India, China) Industry Guide 2014-2023
Published by
MarketLine
Product code
483010
Published
February 25, 2020
Content info
126 Pages
Price
USD 995
Sample available
*
Branded Generics Market, By Drug Class, By Formulation, By Indication, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Published by
Coherent Market Insights
Product code
924607
Published
January 30, 2020
Content info
176 Pages
Price
USD 4500
Sample available
*
Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
Published by
Transparency Market Research
Product code
926768
Published
January 8, 2020
Content info
232 Pages
Price
USD 5795
Sample available
Japan Biosimilars- Landscape Today Outlook Tomorrow - "Biosame" entry, uninterrupted supply and companies' strong front-end footprint requirement makes it distinct
Japan Biosimilars- Landscape Today Outlook Tomorrow - "Biosame" entry, uninterrupted supply and companies' strong front-end footprint requirement makes it distinct
Published by
MP Advisors
Product code
920744
Published
January 6, 2020
Content info
156 Pages
Price
USD 4500
Sample available
*
Europe Biosimilar Insulin Glargine & Lispro Market, By End User (Type 1 Diabetes and Type 2 Diabetes),By Country, Competition, Forecast & Opportunities, 2024
Published by
TechSci Research
Product code
923850
Published
January 1, 2020
Content info
86 Pages
Price
USD 3950
Sample available
*
Asia Pacific Biosimilar Insulin Glargine & Lispro Market, By End User (Type 1 Diabetes and Type 2 Diabetes), By Country (Japan, China, India, South Korea, Bangladesh, Pakistan), Competition, Forecast & Opportunities, 2024
Published by
TechSci Research
Product code
923848
Published
January 1, 2020
Content info
93 Pages
Price
USD 3950
Sample available
Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future
Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future
Published by
BCC Research
Product code
920064
Published
December 23, 2019
Content info
74 Pages
Price
USD 3950
Sample available
Global Biosimilars Partnering Terms and Agreements 2014 to 2019
Global Biosimilars Partnering Terms and Agreements 2014 to 2019
Published by
Current Partnering, a division of Wildwood Ventures Limited
Product code
712891
Published
December 1, 2019
Content info
90+ Pages
Price
USD 1995
Sample available
*
Global Biosimilar's Market - 2019-2026
Published by
DataM Intelligence
Product code
757889
Published
November 1, 2019
Content info
Price
USD 3750
Sample available
Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030
Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030
Published by
ROOTS ANALYSIS
Product code
914380
Published
October 31, 2019
Content info
231 Pages
Price
USD 4499
Sample available

About Contact User Guide Privacy Policy Terms and Conditions Site Map

© Copyright 1997-2020, Global Information, Inc. All rights reserved.